Bridion 200 MG/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FBFPB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,970
Award facts
- Contract value 100% obligated
- $20,969.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,969.50 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Bridion (sugammadex) is a neuromuscular blockade reversal agent used in military and veteran healthcare settings to manage anesthesia-related complications.
This delivery order is a child contract stemming from AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The contract demonstrates the vendor's continued capability to fulfill federal medical procurement requirements through open competition and positions the company as a critical supplier within the DLA's pharmaceutical procurement strategy.
Quick answers
Who was awarded contract SPE2DB25FBFPB?
SPE2DB25FBFPB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FBFPB worth?
The government has obligated $20,970 on SPE2DB25FBFPB.
Is contract SPE2DB25FBFPB an order under another contract?
Yes. SPE2DB25FBFPB is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBFPB competed?
The extent of competition for SPE2DB25FBFPB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award